Board of directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Chris Boerner, PhD >

Board Chair and Chief Executive Officer

Theodore R. Samuels >

Lead Independent Director and Retired President of Capital Guardian Trust Company

Peter J. Arduini >

President and Chief Executive Officer of GE Healthcare

Deepak L. Bhatt, MD, MPH  >

Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine 

Julia A. Haller, MD >

Ophthalmologist-in-Chief, Wills Eye Hospital

Michael R. McMullen >

Former President and CEO, Agilent Technologies, Inc.

Manuel Hidalgo Medina, MD, PhD >

Chief, Division of Hematology and Medical Oncology, Weill Cornell Medical College and Attending Physician, New York-Presbyterian Hospital

Paula A. Price >

Former Executive Vice President and Chief Financial Officer, Macy’s, Inc.

Derica W. Rice >

Former Executive Vice President, CVS Health and President, Pharmacy Benefits Business, CVS Caremark. Former Executive Vice President and Chief Financial Officer, Eli Lilly Company

Karen H. Vousden, PhD >

Principal Group Leader of The Francis Crick Institute and Former Chief Scientist of Cancer Research UK

Phyllis R. Yale >

Advisory Partner, Bain & Company